Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 14 | $5,999,240 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
15 Jun 2023 16:37 | BCRX | BIOCRYST PHARMACEUTICALS INC | SANDERS MACHELLE | Director | 15 Jun 2023 | Sale | 4,000 | 7.98 | 31,920 | D |
15 Jun 2023 16:33 | BCRX | BIOCRYST PHARMACEUTICALS INC | HUTSON NANCY J | Director | 14 Jun 2023 | Sale | 12,866 | 8.04 | 103,443 | D |
05 Apr 2023 16:33 | BCRX | BIOCRYST PHARMACEUTICALS INC | THACKRAY HELEN M. | Chief R&D Officer | 03 Apr 2023 | Sale | 7,000 | 8.29 | 58,030 | D |
02 Feb 2023 17:20 | BCRX | BIOCRYST PHARMACEUTICALS INC | STONEHOUSE JON P | President & CEO | 01 Feb 2023 | Sale | 100,000 | 10.38 | 1,038,000 | D |
19 Dec 2022 17:09 | BCRX | BIOCRYST PHARMACEUTICALS INC | STONEHOUSE JON P | President & CEO | 15 Dec 2022 | Sale | 14,100 | 10.9 | 153,690 | D |
19 Dec 2022 16:58 | BCRX | BIOCRYST PHARMACEUTICALS INC | THACKRAY HELEN M. | Chief R&D Officer | 15 Dec 2022 | Sale | 3,125 | 10.89 | 34,031 | D |
19 Dec 2022 16:55 | BCRX | BIOCRYST PHARMACEUTICALS INC | DOYLE ANTHONY | Chief Financial Officer | 15 Dec 2022 | Sale | 5,700 | 10.9 | 62,130 | D |
19 Dec 2022 16:48 | BCRX | BIOCRYST PHARMACEUTICALS INC | GAYER CHARLES K | Chief Commercial Officer | 15 Dec 2022 | Sale | 6,100 | 10.9 | 66,490 | D |
19 Dec 2022 16:45 | BCRX | BIOCRYST PHARMACEUTICALS INC | JONES MICHAEL L | Exec. Director, Finance - PAO | 15 Dec 2022 | Sale | 445 | 10.9 | 4,850 | D |
19 Dec 2022 16:38 | BCRX | BIOCRYST PHARMACEUTICALS INC | BARNES ALANE P | Chief Legal Officer | 15 Dec 2022 | Sale | 4,175 | 10.88 | 45,424 | D |
02 Dec 2022 18:36 | BCRX | BIOCRYST PHARMACEUTICALS INC | JONES MICHAEL L | Exec. Director, Finance - PAO | 01 Dec 2022 | Sale | 8,600 | 13.01 | 111,886 | D |
02 Dec 2022 18:33 | BCRX | BIOCRYST PHARMACEUTICALS INC | STONEHOUSE JON P | President & CEO | 02 Dec 2022 | Sale | 82,656 | 12.8 | 1,057,997 | D |
02 Dec 2022 18:33 | BCRX | BIOCRYST PHARMACEUTICALS INC | STONEHOUSE JON P | President & CEO | 01 Dec 2022 | Sale | 214,917 | 13 | 2,793,921 | D |
16 Nov 2022 16:19 | BCRX | BIOCRYST PHARMACEUTICALS INC | BABU YARLAGADDA S | Chief Discovery Officer | 14 Nov 2022 | Sale | 31,515 | 13.88 | 437,428 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)